IMCAS Annual World Congress 2019 is one of the most important congresses in the aesthetic science calendar. Dermatologists, plastic surgeons and other aesthetic professionals will come to Paris from all over the world to update their skills. This year IMCAS celebrates 21th anniversary and we are going to be part of it. Visit us at our booth #7
For more information go to the event website
EMSCULPT® is intended for the treatment of obesity by fat reduction through neuromuscular stimulation and increase of the blood flow. *Data on file.
BTL EMSELLA® is indicated for pelvic floor muscle strengthening for treatment of urinary incontinence.
The BTL EXILIS ULTRA 360™ is intended for obesity treatment by means of controlled reduction of fat cells, induced by radiofrequency field in cooperation with ultrasound. Treatment of sexual dysfunction after vaginal delivery by means of improvement of vaginal laxity. BTL VANQUISH ME™ is intended for aesthetic procedures, such as body shaping and circumferential reduction. BTL UNISON® is intended for aesthetic procedures, such as body shaping, skin tightening, reduction of cellulite. BTL EXILITE® is intended to be used in dermatology and general surgical procedures such as treatment of vascular lesions, pigmented lesions, acne, skin rejuvenation, pain relief and hair removal. BTL X-WAVE™ supports local microcirculation what results in local metabolism enhancement. BTL®, EXILITE®, EXILIS®, VANQUISH® and UNISON® are registered trademarks in the United States of America, the European Union and/or other countries. The products, the methods of manufacture or the use may be subject to one or more U.S. or foreign patents or pending applications.
Results and patient experience may vary. As with any medical procedure, ask your doctor if the procedure is right for you.
This site is not intended for US customers. US customers, click here.
We are protecting our clients‘ personal data responsibly. Read more.